Vortioxetine Completed Phase 4 Trials for Age-associated Cognitive Impairment Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03272711Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training